(Q39626623)
Statements
1 reference
Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MS. (English)
1 reference
Laura J Balcer
1 reference
Steven L Galetta
1 reference
Peter A Calabresi
1 reference
Eric Eggenberger
1 reference
Chris H Polman
1 reference
Annie Zhang
1 reference
James V Scanlon
1 reference
Robert Hyde
1 reference
21 April 2012
1 reference
1 reference
318
1 reference
1-2
1 reference
119-124
1 reference
Identifiers
1 reference
1 reference